All clear for Fonterra WPC
Additional independent testing has definitively established that there was no presence of Clostridium botulinum in Fonterra’s whey protein concentrate ingredient and the products made using it, including infant formula, the company reports. This was additional testing commissioned by MPI of the original samples tested by AgResearch which led to Fonterra and MPI initiating the precautionary recall. The latest independent research involved a total of 195 tests carried out in both the US and New Zealand.
Chief executive Theo Spierings says, while there is a sense of shared relief that the product was not contaminated, Fonterra had done the right thing by initiating a precautionary recall. “Food safety remains our number one priority. The original results from AgResearch indicated the presence of toxin-producing Clostridium botulinum in the affected whey protein concentrate and we could therefore not take any chances,” he notes. “We have just learned of the further and definitive test results. While we share a sense of relief about them, this in no way lessens our commitment to undertaking a thorough review into what happened, and to learn from this experience.”
Spierings acknowledges there had been confusion and anxiety arising from the complexity of the precautionary recall and apologises for it. “The past few weeks have been very difficult for parents in a number of countries, as well as for our customers, our farmers, and our staff. For me, as Fonterra’s CEO and as a father of three children, I truly believe that in initiating the recall, we took the right decision and did the right thing at the most critical moment. Given the same circumstances, and with food safety always front of mind, I would do the same again.”
Fonterra has now created a new role of Group Director, Food Safety and Quality, that reports directly to Spierings. “The news does not affect the various reviews and inquiries underway. We are committed to learning from, and sharing, any findings about how we can improve. We will do this in an open and transparent way,” Spierings says.
